Good Morning!
PositiveID Corp. (PSID) is currently trading at only $0.01 but this little med-tech marvel is a little famous around the team.
Some of you recall PSID for its back-to-back WINS from last year: the last two scored us 55% and then again 18% in short order.
Since then, healthcare stocks took it on the chin. The team was long out of PSID by then, of course . . . although I see signs of a revival underway.
Yeah, the gap from $0.010 to $0.011 isn’t huge in absolute numbers, but the percentages feel just as good! And I think there’s MORE ahead!
Here’s what PSID has been up to and where the opportunity is now:

Sad couple of months, but they’re behind us now -- part of that freak sell-off in Big Pharma, biotech, hospitals, you name it.
What attracts my eye here is PSID’s efforts to build a base above $0.01. Double bottom is a good thing if it means the knife has stopped falling.
Naturally those intraday stretches off that base are where the FUN starts! Even a TENTH of a penny at these levels is a cool 9-10% return.
When was the last time you saw the index funds hit that number in an entire YEAR of the “buy and hold?”
Of course you need to rub more than a few PSID shares together to turn those percentages into folding money, but things still look nice and liquid.
A thousand, a hundred thousand, even a MILLION shares changing hands on the right day actually add up to something nice, extremely fast!
And yeah, PSID looks like it’s just starting to bounce out of technically oversold conditions. I circled a few historical parallels up there.
Remember, PSID is that virus detection company that turned into such a headline machine last year. When the news is on its side, it “responds.”
Anthrax, bird flu, you know the story: PSID teamed up with Boeing and booked $2.5 million on the deal. NASA and the Pentagon are on the table.
The prototype is ready to go, functioning as intended. Now the sales cycle can begin and this little company can PROVE itself!
Some people are buzzing about how PSID can detect Zika, which makes it a headline topic in the Third World these days.
They also have new products to work on after buying an advanced thermometer company. Sales margins are already “extremely attractive!”
You know how PSID can build buzz from analysts and institutional investors and even the market media when the wind blows the right way.
And now I think the chart is ready to turn! Maybe today’s the day to reap that PSID whirlwind . . . did you miss it as much as I did?
Sincerely,
Michael Reef
yourstockguy@gmail.com